Histone Deacetylase Inhibitors as Cancer Therapeutics

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."

Steven Grant (Volume editor)

9780123943873, Elsevier Science

Hardback, published 14 December 2012

288 pages
22.9 x 15.1 x 2.3 cm, 0.55 kg

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."

1. Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
2. Mechanisms of Resistance to Histone Deacetylase Inhibitors
3. HDAC Inhibitors: Roles of DNA Damage and Repair
4. HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
5. Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
6. Histone Deacetylase Inhibitors and Rational Combination Therapies
7. HDAC Inhibitors and Chaperone Function

 

Subject Areas: Microbiology [non-medical PSG], Enzymology [PSBZ], Genetics [non-medical PSAK], Pharmacology [MMG]